Titlebook: New Technologies in Surgical Oncology; Antonio Mussa Book 2010 Springer-Verlag Milan 2010 Interventional radiology.Minimal invasive surger

Herbaceous

書目名稱New Technologies in Surgical Oncology影響因子(影響力)




書目名稱New Technologies in Surgical Oncology影響因子(影響力)學(xué)科排名




書目名稱New Technologies in Surgical Oncology網(wǎng)絡(luò)公開度




書目名稱New Technologies in Surgical Oncology網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱New Technologies in Surgical Oncology被引頻次




書目名稱New Technologies in Surgical Oncology被引頻次學(xué)科排名




書目名稱New Technologies in Surgical Oncology年度引用




書目名稱New Technologies in Surgical Oncology年度引用學(xué)科排名




書目名稱New Technologies in Surgical Oncology讀者反饋




書目名稱New Technologies in Surgical Oncology讀者反饋學(xué)科排名

一大群

Radioguided Surgery in Oncological Surgery,f gamma detection probe technology in radioguided surgery has expanded tremendously and has evolved into what is now considered an established discipline within the practice of surgery, revolutionizing the surgical management of many malignancies, including breast cancer, melanoma and colorectal can

irreparable

Prosthetic Materials in Surgical Oncology, investigational trials have shown the possibility of carcinogenic stimulation by foreign bodies introduced into the body, like those by Vasiliev and Moizhess in 1982 [.], where polyvinyl hydrochloride film was inserted into the abdomen of some rats and some sarcomatous cells were subsequently intro

cunning

Intraoperative Radiotherapy,y is applied in association with surgery and external beam radiotherapy (EBRT) or chemotherapy in the treatment of locally advanced cancer of the abdomen, pelvis, neck, cranium, thorax and extremities [.] with the final goal of enhancing locoregional tumor control [.]. The initial clinical use of IO

FUSC

New Technologies in Oncological Endocrine Surgery,d alone. In this chapter all innovations which may be considered technical and technological in nature and which have passed through recent surgical practice in oncology will be systematically examined, while attempting to methodically maintain order for each organ.

猛然一拉

Endoscopy and Surgical Oncology,y has been a major advance, and most recently ablation and endoscopic mucosal resection seem to be highly successful in treating flat neoplastic areas involving the gut mucosa. The use of endoscopic ultrasonography (EUS) has resulted in improved accuracy for cancer staging, and EUS-guided fine-needl

Extemporize

成績上升

Transplants in Surgical Oncology,inal liver failure, including hepatocellular carcinoma (HCC). In 1996 Mazzaferro published the results obtained on selected patients affected with HCC. He showed a 4 year survival rate of 75%, comparable to the rate obtained on patients who were transplanted for non tumoral pathology (78.3%) [.].

使殘廢

correspondent

Hemostatic Agents in Surgical Oncology,o FDA regulations, an hemostatic agent is defined as a device intended to produce hemostasis by accelerating the clotting process of blood. Broadly these agents can be thought of as topical hemostats, fibrin sealants, matrix hemostats and fibrin-coated collagen patch.